US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

240.49

+0.99820.42%

Volume:47.61K

Turnover:11.45M

Market Cap:477.73M

PE:- -

High:241.58

Open:239.94

Low:239.85

Close:239.49

52wk High:244.35

52wk Low:160.91

Shares:1.99M

Float Shares:1.99M

Volume Ratio:5.99

T/O Rate:2.40%

Dividend:0.95

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS

Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE

Simply Wall St.

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Political and General News Events from August 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240

THOMSON REUTERS

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BBH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":240.49,"timestamp":1788372541016,"preClose":239.4918,"halted":0,"volume":47614,"delay":0,"changeRate":0.004167992390553652,"floatShares":1986503,"shares":1986503,"eps":0,"marketStatus":"Trading","change":0.9982,"latestTime":"09-02 14:09:53 EDT","open":239.94,"high":241.58,"low":239.85,"amount":11453227.25778,"amplitude":0.007224,"askPrice":241.67,"askSize":200,"bidPrice":241.44,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":239.4918,"sharesOutstanding":1976503,"nav":236.27832,"aum":469367592.63,"dividendRate":0.003933,"bidAskSpread":0.001117,"preHourTrading":{"tag":"盘前","latestPrice":239.49,"preClose":239.4918,"latestTime":"04:56 EDT","volume":1,"amount":239.49,"timestamp":1788339417440,"change":-0.0018,"changeRate":-0.000008,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":239.0965,"preClose":239.4918,"latestTime":"16:23 EDT","volume":18,"amount":4311.9544,"timestamp":1788294232639,"change":-0.3953,"changeRate":-0.001651,"amplitude":0},"volumeRatio":5.990164,"impliedVol":0.1934,"impliedVolPercentile":0.4921},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1986503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":5.990164,"shares":1986503,"dividePrice":0.9459,"high":241.58,"amplitude":0.007224,"preClose":239.4918,"low":239.85,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":240.49,"eps":0,"divideRate":0.003933,"volume":47614,"delay":0,"ttmEps":0,"open":239.94,"prevYearClose":189.2649,"prevWeekClose":236.4764,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":242.67,"twentyDayClose":210.4939,"sixtyDayClose":186.0541},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664837149","title":"UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837149?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:29","pubTimestamp":1788254980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S0UF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMGN","BK4599","IE00B2B36J28.USD","BK4585","LU2089984988.USD","LU0289739699.SGD","SG9999001440.SGD","BK4534","IE0002141913.USD","BK4588","LU2468319806.SGD","PJP","LU1571399168.USD","BK4566","BK4581","LU2242652126.USD","IE0009355771.USD","LU0868494617.USD","LU2242646821.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4533","IBB","IBBQ","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU1983299246.USD","TBXU","BBH","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2112291526.USD","BK4139","BIB","PBE","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883781","title":"Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883781","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883781?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:22","pubTimestamp":1788250932,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) is in focus after the FDA approved RASONQUE, an oral RAS(ON) inhibitor for adults with metastatic pancreatic adenocarcinoma following prior systemic therapy or for those unsuitable for multiagent regimens.\nRevolution Medicines’ share price is around US$205.57 after a slight pullback over the past week. The 30 day share price return of 9.62% and 90 day share price return of 35.86% sit against a year to date share price return of 160.15%, while the 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-rvmd-could-be-7-below-fair-value-on-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-rvmd-could-be-7-below-fair-value-on-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BFTCPJ56.SGD","LU0109394709.USD","LABU","LU1978683503.SGD","IE00BFMHRM44.USD","BK4139","LU1548497426.USD","IE0002141913.USD","PTH","IE00B2B36J28.USD","ONX","IE0009354923.USD","IE00BZ199S13.USD","IE00BJJMRZ35.SGD","LU1861219969.SGD","LU1861214812.USD","LU1983260115.SGD","RVMD","BK4585","BK4605","BBH","LU0889565916.HKD","LU1720051108.HKD","LU1854104046.USD","IDNA","LU0724618433.USD","IE0009355771.USD","BK4588","IE00BJT1NW94.SGD","LU0124384867.USD","LU2357305700.SGD","BK4141","LU0320765992.SGD","LU1720051017.SGD","LU2360107325.USD","IE00B4R5TH58.HKD","CANC","LU1854103824.USD","LU1861220033.SGD","IE00BD6J9T35.USD","LU2298322129.HKD","LU0348723411.USD","LU1861215975.USD","ON","ONG","BK4512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832384","title":"Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832384","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:18","pubTimestamp":1788250703,"startTime":"0","endTime":"0","summary":"Amgen (NasdaqGS:AMGN) reported new Phase 3 VESALIUS-CV trial results for Repatha (evolocumab) showing a reduction in risk of death for high-risk adults without prior heart attack or stroke, presented at the European Society of Cardiology Congress 2026.\nThe findings extend evidence for Repatha to a broader high-risk population beyond patients with established cardiovascular events.\nAmgen highlighted that the data may inform future treatment guidelines and prescribing decisions in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AMGN","BK4599","IE00B2B36J28.USD","BK4585","LU2089984988.USD","LU0289739699.SGD","SG9999001440.SGD","BK4534","IE0002141913.USD","BK4588","LU2468319806.SGD","PJP","LU1571399168.USD","BK4566","BK4581","LU2242652126.USD","IE0009355771.USD","LU0868494617.USD","LU2242646821.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4533","IBB","IBBQ","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU1983299246.USD","TBXU","BBH","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2112291526.USD","BK4139","BIB","PBE","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0417517546.SGD","IBBQ","SG9999001176.USD","PBE","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU2456880835.USD","LU0058720904.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU1430594728.SGD","ACKY","IDNA","BRKW","IE00B19Z9P08.USD","LU1585245621.USD","IE00BJT1NW94.SGD","LU1778281490.HKD","BRKD","GNMX","ACTV","IBB","LU0109394709.USD","BK4139","BRKL","LU0889565916.HKD","LU2362541513.USD","VERX","LU0061475181.USD","LU1559883803.SGD","LU1069344957.HKD","LU1674673428.USD","VRTX","LU1815336091.USD","BK4567","LU2462157665.USD","LU0256863811.USD","IE00BZ9MQY76.HKD","LU1035775433.USD","IE00BFTCPJ56.SGD","BBH","BIB","LU0757428866.USD","BRKC","TBXU","BRKU","LU2237438978.USD","BK4588","IE0002141913.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IE0009355771.USD","LU0061475181.USD","IE00B19Z3B42.SGD","SG9999001176.USD","VRTX","BK4585","LU0889565916.HKD","IE00BZ9MQY76.HKD","LU2417539215.USD","PBE","IE00B19Z3581.USD","BBH","BK4532","BIB","GNMX","LU1069344957.HKD","TBXU","BK4588","VERX","IE00B2B36J28.USD","LU1815336091.USD","IE0002141913.USD","LU1778281490.HKD","LU0823416689.USD","LU2089984988.USD","IBBQ","LU0234570918.USD","LU2324357040.USD","LU1674673691.USD","LU0432979614.USD","IE00B19Z9Z06.USD","CDIG","SG9999001176.SGD","LU1430594728.SGD","LU1559883803.SGD","LU2362540622.SGD","SGXZ57979304.SGD","LU0566484027.USD","LU1035775433.USD","LU0109394709.USD","LU1674673428.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0079474960.USD","IBB","TSPA","TACU","IDNA","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854881","title":"Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854881","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854881?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:17","pubTimestamp":1788218267,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, based on Phase 3 OPTIMA trial data.\nThis approval introduces a new rare disease therapy that can be infused monthly, including in home settings, and is supported by strong lesion-reduction outcomes against placebo while carrying...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LU0053666078.USD","LU0114720955.EUR","LU1917777945.USD","LU2089984988.USD","LU2362540622.SGD","LU2106854487.HKD","LU0058720904.USD","LU0109394709.USD","ARTY","LU0320765992.SGD","BK4585","AIPO","LU0882574055.USD","TBXU","LU1974910355.USD","VTHR","LU0823416689.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD","REGN","LU2362541513.USD","LU0823434740.USD","LU0289739699.SGD","LU0889565916.HKD","LU2023250504.SGD","BK4195","CHAT","LU2362541273.HKD","HBCP","IBBQ","IBB","AGIX","BK4211","BBH","BK4139","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU2468319806.SGD","PJP","TBXU","BK7511","LU1983299246.USD","IE00BBT3K403.USD","IE00BJT1NW94.SGD","BK4007","PFE","PBE","688235","SGXZ57979304.SGD","IE0002270589.USD","LU0321505439.SGD","AMGN","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0889565916.HKD","BIB","SG9999001176.SGD","BK4566","IONS","LU0225284248.USD","LU0868494617.USD","SG9999002224.SGD","CSL.AU","LU2242646821.SGD","BK4505","BK4550","IE00BLSP4452.SGD","IE00B3T34201.USD","IBB","IE0002141913.USD","BBIO","BK0012","BK0046","LU1883839398.USD","LU0306806265.USD","IBBQ","BBH","OZEM","IE00BLSP4239.USD","LU1057294990.SGD","BK0028","300485","LU0320765992.SGD","LU0109394709.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","IBB","BK4585","LU1571399168.USD","PBE","LU1061106388.HKD","BK4581","BK4566","LU0109394709.USD","IBBQ","LU2242652126.USD","BK4588","IE00BJT1NW94.SGD","LU0058720904.USD","LU0868494617.USD","IE0002141913.USD","BK4139","AMGN","LU1023059063.AUD","LU1983299246.USD","LU2468319806.SGD","BK4534","IE0009355771.USD","BK4599","LU2089984988.USD","PJP","IE00B2B36J28.USD","BBH","IE00BFTCPJ56.SGD","LU0122379950.USD","SG9999001440.SGD","BK4533","TBXU","LU1057294990.SGD","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739699.SGD","IBB","LU2468319806.SGD","BK4599","LU2089984988.USD","LU2242646821.SGD","LU0320765992.SGD","BK4581","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4566","PJP","LU0058720904.USD","BK4534","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0868494617.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE0002141913.USD","BIB","IBBQ","LU1983299246.USD","AMGN","LU2242652126.USD","LU1571399168.USD","SG9999001440.SGD","LU1023059063.AUD","TBXU","IE0009355771.USD","LU0122379950.USD","LU1061106388.HKD","PBE","LU0889565916.HKD","LU0109394709.USD","BK4139","BK4585","BBH","BK4533","IE00BFTCPJ56.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079265","title":"Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079265?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:45","pubTimestamp":1788169510,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDNA","IE0009354923.USD","CANC","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","RVMD","LU0320765992.SGD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","BBH","IE00BFTCPJ56.SGD","PTH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","PJP","BK4599","LU1023059063.AUD","BK4588","LU1061106388.HKD","LU2468319806.SGD","TBXU","LU2112291526.USD","BIB","IBBQ","BK4585","IE00BJT1NW94.SGD","IE0002141913.USD","BK4534","LU0889565916.HKD","IBB","LU1983299246.USD","LU2242652126.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0058720904.USD","LU1057294990.SGD","LU2242646821.SGD","BK4566","BK4533","LU0320765992.SGD","BK4139","LU0868494617.USD","LU1571399168.USD","SG9999001440.SGD","PBE","IE00B4R5TH58.HKD","AMGN","LU0122379950.USD","BK4581","LU2089984988.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0058720904.USD","LU2112291526.USD","LU2468319806.SGD","LU1061106388.HKD","PJP","BK4139","BK4588","LU1057294990.SGD","LU1983299246.USD","SG9999001440.SGD","BBH","BK4534","AMGN","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2242652126.USD","LU0889565916.HKD","LU0868494617.USD","BK4581","IBBQ","LU0122379950.USD","IE0009355771.USD","LU2242646821.SGD","BK4533","PBE","IE00BJJMRZ35.SGD","BK4585","LU2089984988.USD","IE0002141913.USD","TBXU","LU1571399168.USD","LU1023059063.AUD","IE00B2B36J28.USD","IBB","BK4599","BIB","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1571399168.USD","BMED","GILD","BK4583","LU1934455277.USD","LU0058720904.USD","BK4550","LU1934455863.HKD","LU1430594728.SGD","BK4578","BK4566","LU0114720955.EUR","LU1839511570.USD","LU0965508806.USD","LU0234570918.USD","LU2089984988.USD","BBH","LU1934455194.USD","LU0965509010.AUD","BK4532","LU1585245621.USD","LU1066051498.USD","IE00B3T34201.USD","MEDI","LU0122379950.USD","LU1066053197.SGD","IBBQ","BK4568","LU2468319806.SGD","LU2112291526.USD","BK4139","IBB","LU1023059063.AUD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU0823416689.USD","SG9999015945.SGD","BK4585","LU2324357040.USD","BK4588","LU0882574055.USD","LU0965509283.SGD","TMED","IE00B19Z3B42.SGD","LU0109394709.USD","BIB","IE00BKVL7J92.USD","LU0289739699.SGD","SG9999015978.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663464017","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663464017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663464017?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:30","pubTimestamp":1788013830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Spyre Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XBI","BK4139","SYRE","LFSC","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0109394709.USD","XLV","HCSG","IDNA","LABU","PTH","BK4588","LU0320765992.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","CANC","LU0889565916.HKD","IE0009354923.USD","RVMD","BK4581","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4585","BBH","IE00BJT1NW94.SGD","LU0029874061.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019778","title":"Pharma Industry Stares Down Biggest Patent Cliff in Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019778?lang=en_us&edition=fundamental","pubTime":"2026-08-29 09:00","pubTimestamp":1787965200,"startTime":"0","endTime":"0","summary":"Most companies sell a hit product for as long as customers want it. For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","VHT","LU1883839398.USD","LU0320765489.SGD","IHE","LU0320765646.SGD","LU0980610538.SGD","GLAM","LU1037948541.HKD","LU0267386448.USD","LU1989772923.USD","LU0683600562.USD","LU2357305700.SGD","LU0203345920.USD","SG9999015952.SGD","LU1548497426.USD","LU1162221912.USD","LU0477156953.USD","LU2491050154.USD","IE00BGHQF631.EUR","RXL","LU1720051017.SGD","RVMD","SG9999014559.SGD","LU1244550494.USD","BK4548","LU0154236417.USD","LU0323591593.USD","LU1979441026.SGD","LU0471298777.SGD","LU1496350171.SGD","LU2111349929.HKD","LU0237698245.USD","LU0256863902.USD","IE00B19Z3581.USD","GDOC","LU0859254822.USD","LU0306806265.USD","BK4566","IE00BFSS8Q28.SGD","LU0823434583.USD","BK4533","LU1032466523.USD","BK4599","LU2456880835.USD","BK4559","LU0057025933.USD","LU1839511570.USD","LU0289961442.SGD","LU1670711040.USD","BBH","IE00BKDWB100.SGD","LU0097036916.USD","NVOX","LU1989771016.USD","IE00B4JS1V06.HKD","LU0354030511.USD","LU2125154935.USD","LU0820562030.AUD","LU0889565916.HKD","GNOM","MEDI","LU0472753341.HKD","LU1267930490.SGD","LU1236620750.USD","SGXZ81514606.USD","LU0471298694.HKD","IE00B1BXHZ80.USD","LU0942090050.USD","SGXZ31699556.SGD","LU2125909247.SGD","LU0289739343.SGD","BK4532","LU1732800096.USD","IE00BBT3K403.USD","LU0208291251.USD","LU2125909593.SGD","WDNA","NVOH","SGXZ51526630.SGD","IE00BSNM7G36.USD","LU1929549753.HKD","IE00BFSS7M15.SGD","SG9999001176.USD","IE00BLSP4452.SGD","LU0545039389.USD","IYH","BK4139","LU0211328371.USD","LU2023250843.SGD","MRK","LU0006306889.USD","SG9999015358.SGD","IE00BWXC8680.SGD","IE000BZT7R73.USD","LU2028103732.USD","LU2756315664.SGD","LU1145028129.USD","LU0949170772.SGD","IE00BKPKM429.USD","LU2237443465.HKD","LU0320765992.SGD","LU2602419157.SGD","LU1868837136.USD","LU1074936037.SGD","SG9999002224.SGD","LU2213496289.HKD","BK4588","LU2552382132.HKD","LU0786609619.USD","LU1066051225.USD","MRNX","LU0985320562.USD","LU0238689110.USD","LU1066051498.USD","LU1093756325.SGD","PJP","LU1868836591.USD","CURE","LU0823416689.USD","LU0640476718.USD","IE0002270589.USD","LU0130517989.USD","LU0868494617.USD","LU1923622614.USD","LU0289739699.SGD","IXJ","LU0321505868.SGD","LU2023250504.SGD","IE00B4R5TH58.HKD","LU1037948897.HKD","BK4581","LU1366192091.USD","LU0882574055.USD","LU1035773651.USD","LU0708994859.HKD","LU1814569148.SGD","LU2133065610.SGD","LU0203202063.USD","LU0795875169.SGD","LU0820561818.USD","LU2361044949.HKD","LU1551013342.USD","LU2236285917.USD","LU2896262040.SGD","HRTS","FHLC","LU0395794307.EUR","LGHT","LU2112291526.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE000SO60NU8.SGD","LU0096364046.USD","IE0000B7K699.USD","LU1868837300.USD","LU2129689431.USD","LU0787776722.HKD","AGNG","LU0316494557.USD","IE00BFTCPJ56.SGD","BMED","LU2242646821.SGD","LU0321505439.SGD","LU2089984988.USD","LU0069063385.USD","LU2023250330.USD","LU0225771236.USD","IE00B3PB1722.GBP","LU0310800379.SGD","LU1941712264.USD","SG9999014575.USD","LU0354030438.USD","LU0965509101.SGD","MRNA","LU0158827948.USD","IE00BJJMRZ35.SGD","LU2271345857.HKD","SG9999014542.SGD","LU1712237335.SGD","LU2552382058.USD","LLYZ","LU1934455277.USD","LU1291159041.SGD","LU2471134952.CNY","LU0553294199.USD","IE00BVYPNV92.GBP","LU0965509010.AUD","LU0708995401.HKD","LU2347655156.SGD","SG9999017495.SGD","LU0122379950.USD","LU1989772840.SGD","LU2746668461.USD","LU1988902786.USD","LU1244550221.USD","LU0058720904.USD","LU1551013425.SGD","LU2168564149.EUR","FTXH","BK4550","LU2417539215.USD","LU2168564222.USD","LU0965508806.USD","LU2242652126.USD","SG9999014914.USD","LU2237443382.USD","LU0964807845.USD","LU2237443895.HKD","LU0256863811.USD","LU1430594728.SGD","LU0079474960.USD","LU1267930573.SGD","LU0320765059.SGD","LU0306807586.USD","LU2750360641.GBP","SG9999001176.SGD","LU0738911758.USD","LU1236620834.HKD","JDOC","IE00B775H168.HKD","LU0210536198.USD","LU1069347547.HKD","LU1934455194.USD","TRUH","ILDR","SGXZ57979304.SGD","LU0689472784.USD","LU0795875086.SGD","LU0266013472.USD","LU2756315318.SGD","LU1629891620.HKD","ELIL","LU0234570918.USD","LU2360032135.SGD","BK4501","LU2462157665.USD","LU0211327993.USD","SGXZ99366536.SGD","LU2468319806.SGD","BK4585","PPH","LU1670628061.USD","LU1670711123.USD","LU1116320901.HKD","LU1066053197.SGD","BK4534","LU2063271972.USD","LU0170899867.USD","BK4007","LU1934455863.HKD","LU2264538146.SGD","IE00BK4W5L77.USD","LU2211815571.USD","LU0861579265.USD","IE00BJJMRX11.SGD","LU1804176565.USD","CANC","LU2746668974.SGD","SG9999011175.SGD","LU1201861249.SGD","LU1280957306.USD","LU0070302665.USD","MEDX","LU1868836757.USD","MRNY","LU0353189680.USD","LU1035775433.USD","LU1670710588.SGD","LU2491049909.HKD","LU2237443622.USD","IE0009354923.USD","LU0098860793.USD","IE000MB6IJN5.SGD","LU0114720955.EUR","LLYX","LU0385154629.USD","IE00BN29S564.USD","LU0029864427.USD","LU2089284900.SGD","LU2596442595.SGD","LU0211331839.USD","IDNA","LU2087625088.SGD","LU2750360997.AUD","LU0466842654.USD","SG9999001440.SGD","LU1623119135.USD","LU0985481810.HKD","LU1699723380.USD","LU2108987350.USD","LU2471134523.USD","LU0198837287.USD","XLV","IE00BN8TJ469.HKD","LU0820561909.HKD","LU2361045086.USD","LU1496350502.SGD","LU1720051108.HKD","LU2265009873.SGD","SG9999003800.SGD","LU0726765562.USD","THNR","LU0882574139.USD","LU2433249047.HKD","LU0130102774.USD","IE0005OL40V9.USD","LU2237438978.USD","LU0511384066.AUD","BK4551","PAWZ","LU1917777945.USD","LLII","LU1974910355.USD","LU0265550359.USD","LU1323610961.USD","LU2360106947.USD","LU1670710661.SGD","NVOC","IE00BJJMRY28.SGD","LU0648001328.SGD","IE00BLSP4239.USD","LU1066051811.HKD","LU1232071149.USD","IE000M9KFDE8.USD","PTH","LU2129689514.USD","LU2552382215.SGD","LU0061475181.USD","LU0174119429.USD","ELIS","IE00B1XK9C88.USD","ABBV","IE00BFXG1179.USD","SG9999018865.SGD","LU0203347892.USD","SG9999014898.SGD","LU2471134796.USD","LU2089283258.USD","IE0001KFT4U8.USD","IE00BDGV0183.EUR","LU0456855351.SGD","LU2324357040.USD","SG9999002232.USD","LU2347655073.USD","LU0689626769.HKD","LU1116320737.USD","LU1941712348.USD","LU2023251221.USD","LU0417517546.SGD","LU2168563687.JPY","LU2361044865.SGD","LU0345770993.USD","LU1244550577.SGD","LU1670627923.USD","LU2237443978.SGD","IE00BJLML261.HKD","LU1868836914.USD","LU0345770308.USD","LU0124676726.USD","BK4568","LU2462591350.SGD","LU0158827781.USD","BMY","SG9999015341.SGD","LU2129689605.HKD","IE0004445239.USD","SG9999015978.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU1571399168.USD","SG9999018857.SGD","LU1718418525.SGD","MHIP","LU0203201768.USD","LU0106261372.USD","LU2471134879.HKD","LU0912757837.SGD","SG9999014906.USD","LU1069344957.HKD","LU2168564495.EUR","LU2087621335.USD","LU0234572021.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","NVO","LU0432979614.USD","LU2168564065.EUR","BK4516","LU0109391861.USD","IE00BKVL7J92.USD","IE00B42XCP33.USD","TMED","OZEM","LLY","LU1003077747.HKD","LU0133085943.USD","LU0868494708.USD","LU0128525929.USD","LU0225284248.USD","IE000WAW04H5.SGD","LU0353189763.USD","LU2125154778.USD","IE000F7OJYX1.SGD","LU0310799852.SGD","LU1061106388.HKD","LU2237443549.SGD","LU1261432733.SGD","LU1023059063.AUD","LU1983299246.USD","GB00BDT5M118.USD","SG9999014880.SGD","LU0225283273.USD","LU1691799644.USD","IE00BK4W5M84.HKD","LU0661504455.SGD","IE00BVYPNW00.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU1732799900.SGD","SG9999013999.USD","LU0943347566.SGD","SG9999015945.SGD","LU1093756168.USD","IE00B7KXQ091.USD","LU0672654240.SGD","SG9999014567.USD","LU0965509283.SGD","LU2461242641.AUD","LU0094547139.USD","LU1064131342.USD","LU1127390331.HKD","LU0265550946.USD","LU1057294990.SGD","IE0009355771.USD","LU2491050071.SGD","LU0823434740.USD","LU1267930730.SGD","LU2357627491.SGD","IE0004445015.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.SGD","LU2468319806.SGD","BK4532","IBBQ","BIB","LU2417539215.USD","IE0009355771.USD","IE0002141913.USD","LU1674673691.USD","BBH","LU1778281490.HKD","IE00B894F039.SGD","LU0061475181.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","BK4585","BK4567","LU0079474960.USD","LU1069344957.HKD","LU2462157665.USD","IDNA","LU0432979614.USD","LU2236285917.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","TBXU","LU0256863811.USD","LU1815336091.USD","LU2362540622.SGD","LU1093756168.USD","LU1674673428.USD","BK4023","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","GNMX","LU0823416689.USD","BK4588","LU0234570918.USD","PBE","LU0757428866.USD","IBB","VERX","BK4533","IE00BJT1NW94.SGD","VRTX","IE00B19Z3581.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0861579265.USD","IBB","LU1839511570.USD","SG9999015952.SGD","SG9999015978.USD","LU1061106388.HKD","LU0320765992.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","LU1571399168.USD","SG9999015986.USD","IE00B19Z3581.USD","IE0002270589.USD","LU0289739699.SGD","LU0965509101.SGD","BK4588","LU2112291526.USD","IE00BSNM7G36.USD","LU1037948897.HKD","LU1066053197.SGD","LU2357627491.SGD","BBH","MEDI","IE00B3T34201.USD","IBBQ","LU0109394709.USD","LU0965508806.USD","LU1934455277.USD","LU2087621335.USD","LU0058720904.USD","LU0965509010.AUD","BK4532","LU0882574055.USD","BK4566","LU1430594728.SGD","LU1037948541.HKD","IE00B7SZLL34.SGD","SG9999015945.SGD","GILD","BMED","LU1057294990.SGD","LU1585245621.USD","LU2468319806.SGD","LU0122379950.USD","LU0234570918.USD","LU0859254822.USD","BK4583","LU0889565916.HKD","LU1778281490.HKD","LU2324357040.USD","LU0823416689.USD","BK4585","BK4139","BK4578","IE00BZ1G4Q59.USD","LU1023059063.AUD","BK4568","IE00BKVL7J92.USD","LU1674673691.USD","LU0114720955.EUR","LU1934455863.HKD","LU2089984988.USD","TMED","LU1674673428.USD","TBXU","LU0965509283.SGD","BIB","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU0109394709.USD","LU1061106388.HKD","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0320765992.SGD","LU2112291526.USD","IE00B2B36J28.USD","BK4534","IE00BJT1NW94.SGD","IBB","LU0122379950.USD","BK4533","PJP","LU0058720904.USD","LU2089984988.USD","BK4566","BBH","LU0868494617.USD","LU1023059063.AUD","TBXU","SG9999001440.SGD","IE0002141913.USD","LU1983299246.USD","BIB","BK4588","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","PBE","LU1057294990.SGD","IBBQ","LU2242652126.USD","04332","LU0289739699.SGD","IE0009355771.USD","BK4599","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0859254822.USD","MEDI","LU0114720955.EUR","TBXU","LU1057294990.SGD","LU1066053197.SGD","BIB","SG9999015986.USD","LABU","IBBQ","LU0965509010.AUD","LU1934455863.HKD","BK4578","LU0109394709.USD","SG9999015978.USD","LU0823416689.USD","LU0882574055.USD","IE00B19Z3B42.SGD","GILD","LU0965509101.SGD","BMED","BK4585","TMED","LU1066051498.USD","BK4532","BK4588","IE00B19Z3581.USD","BK4566","LU1934455194.USD","LU1778281490.HKD","LU1674673691.USD","BBH","LU1037948897.HKD","IE00BSNM7G36.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","BK4139","SG9999015945.SGD","LU1934455277.USD","LU1571399168.USD","IBB","LU0889565916.HKD","LU2357627491.SGD","LU1037948541.HKD","IE00B3T34201.USD","LU0122379950.USD","IE0002270589.USD","LU2112291526.USD","LU1585245621.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097210","title":"Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097210","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934634,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex’s new Phase 1 study, officially titled “A Phase 1, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","LU1815336091.USD","IBBQ","BK4211","SG9999013999.USD","LU0889565916.HKD","LU0417517546.SGD","IE0009355771.USD","LU1585245621.USD","IE00B19Z3581.USD","LU2417539215.USD","LU1559883803.SGD","BK4585","BK4588","LU0823416689.USD","LU2362540622.SGD","BIB","IE0002270589.USD","TBXU","SGXZ57979304.SGD","LU2362541273.HKD","SG9999001176.USD","LU2362541513.USD","BK4139","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","BK4023","LU1674673428.USD","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU2089984988.USD","LU0566484027.USD","LU2324357040.USD","ISBC","LU2468319806.SGD","VERX","LU0320765992.SGD","BBH","IBB","IE00B2B36J28.USD","LU1093756325.SGD","PBE","BK4567","GNMX","IDNA","LU2237438978.USD","LU0058720904.USD","SG9999001176.SGD","LU1430594728.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}